Search results
PROMOTED
Start date:
Jan 21, 2026
Pacemaker implantation remains one of the most common complications after TAVI. In this webinar, chaired by Prof Rafal Dworakowski (Abbott APAC Medical Affairs Director, Singapore, SG) and Dr Simon Lam (Queen Mary Hospital, Hong Kong, HK), leading specialists will focus on the anatomy of the conduction system anatomy, highlight key pre-procedural planning considerations, and share proven…
View more
Added:
1 year ago
ISET 2025 - How have drug delivery devices changed over the years, and what are the novel technologies and therapeutic agents?Dr Marianne Brodmann (Medical University of Graz, AT) joins us onsite at ISET 2025 to discuss the current landscape of drug delivery devices, from paclitaxel drug-coated balloons to drug-eluting stents. Dr Brodmann discusses evolving technologies, including bioresorbable…
View more
Added:
1 year ago
ACC 2025 - EVOLUT Low-Risk findings show the Medtronic TAVR system is a safe and effective treatment for aortic stenosis vs surgical valves at five years.Dr Michael Reardon (Houston Methodist, Texas, US) joins us onsite at ACC to discuss the EVOLUT Low Risk trial (NCT02701283; Medtronic Cardiovascular), investigating the safety and effectiveness of the Medtronic TAVR system compared to surgical…
View more
TCT 23: EVOLUT Low-Risk
Added:
2 years ago
Video
Added:
5 months ago
Dr Matthias Götberg (Skane University Hospital, SE), Dr Karim Al-Azizi (Baylor Scott & White Legacy Heart Center, US) and Prof Farrel Hellig (Sunninghill Hospital, ZA) delve into the evolving field of ultra-low contrast PCI. The faculty explore how interventional cardiologists can achieve procedural precision while significantly reducing contrast usage.Through a combination of expert…
View more
Added:
3 weeks ago
In this chapter of ICE and TEE Guidance for TriClip Tricuspid TEER, Dr Karim Al-Azizi (Baylor Scott & White Health – The Heart Hospital, US) demonstrates the step-by-step technical approach to TriClip tricuspid transcatheter edge‑to‑edge repair (TEER) using a dual‑imaging strategy.The case highlights vascular access techniques, device positioning, and the pivotal role of hybrid transoesophageal…
View more
Start date:
Oct 30, 2025
Join Dr Matthias Götberg (Skane University Hospital, SE), Dr Karim Al-Azizi (Baylor Scott & White Legacy Heart Center, US) and Prof Farrel Hellig (Sunninghill Hospital, ZA) in this webinar as they delve into the evolving field of ultra-low contrast PCI. The faculty will explore how interventional cardiologists can achieve procedural precision while significantly reducing contrast usage.Through a…
View more
Added:
2 years ago
TCT 23 - In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year outcomes from Edwards' PARTNER 3 low-risk trial (NCT02675114).PARTNER 3 is a randomized, prospective, multicenter trial that aimed to determine the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with severe calcific aortic…
View more
Added:
10 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
Added:
9 months ago
New York Valves 2025 - Early outcomes from an observational study with the PASCAL System show a 97% device success rate.Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss a novel TEER device system. This observational study investigated the use of the PASCAL Prescision system in over 2000 patients from the STS/ACC/TVT registry over a period of two years.Findings…
View more